20250177514. Coronavirus Antigen Variants (Pfizer .): Difference between revisions
Wikipatents (talk | contribs) Automated patent report |
Wikipatents (talk | contribs) Automated patent report |
||
| (One intermediate revision by the same user not shown) | |||
| Line 19: | Line 19: | ||
<!-- JSON-LD markup for search engines: | <!-- JSON-LD markup for search engines: | ||
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250177514. Coronavirus Antigen Variants (Pfizer .)","name":"20250177514. Coronavirus Antigen Variants (Pfizer .)","description":"Patent application abstract and classification for 20250177514 - Coronavirus Antigen Variants","datePublished":"2025-06- | {"@context":"https://schema.org","@type":"TechArticle","headline":"20250177514. Coronavirus Antigen Variants (Pfizer .)","name":"20250177514. Coronavirus Antigen Variants (Pfizer .)","description":"Patent application abstract and classification for 20250177514 - Coronavirus Antigen Variants","datePublished":"2025-06-11","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250177514","name":"Coronavirus Antigen Variants","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"Pfizer Inc."}]}} | ||
--> | --> | ||
Latest revision as of 03:41, 11 June 2025
CORONAVIRUS ANTIGEN VARIANTS
Abstract: the present disclosure provides isolated immunogenic polypeptides comprising variant coronavirus spike proteins that are variants of a native coronavirus spike protein or fragment thereof, the variant coronavirus spike proteins having one or more modifications compared to the native coronavirus spike protein that: increase adoption by a receptor binding domain (rbd) of the variant coronavirus spike protein of an up conformation; and/or decrease adoption by a rbd of the variant coronavirus spike protein of a down conformation; and/or increase expression of the variant coronavirus spike protein compared to the native coronavirus spike protein; and/or increase adoption of a prefusion conformation; and/or decrease shedding of a s1 subunit of the variant coronavirus spike protein; and/or improve localization of the variant coronavirus spike protein to a host cell membrane. the present disclosure also provides compositions comprising the isolated immunogenic polypeptides and methods of making and using such compositions.
Inventor(s): Ye CHE, Kena Anne SWANSON
CPC Classification: A61K39/215 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250177514